Sullivan Christopher Ryan
CIK 0001810417
Chief Financial Officer
Filings
15
Latest May 26, 2026
Issuers covered
1
Showing
15 of 15
Page 1
Track record
7 of 13 open-market trades scored (54% price coverage) - 6 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 57% | -7.5% | +17.9% | +22.4% | -90.9% |
| 90 days | 1 | 0% | -97.6% | -97.6% | -97.6% | -97.6% |
| 180 days | 1 | 0% | -98.4% | -98.4% | -98.4% | -98.4% |
| 365 days | 1 | 0% | -98.9% | -98.9% | -98.9% | -98.9% |
Issuers
Companies where Sullivan Christopher Ryan has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 15 | May 26, 2026 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|